Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32299723)

Published in Clin Oncol (R Coll Radiol) on April 09, 2020


C M Jones1, M Hawkins2, S Mukherjee3, G Radhakrishna4, T Crosby5

Author Affiliations

1: School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK; Radiotherapy Research Group, Leeds Institute of Medical Research at St James's, Faculty of Medicine & Health, University of Leeds, Leeds, UK; Leeds Cancer Centre, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
2: Department of Medical Physics & Biomedical Engineering, University College London, London, UK.
3: CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
4: Christie Hospital, The Christie NHS Foundation Trust, Manchester, UK.
5: Velindre Cancer Centre, Cardiff, UK. Electronic address: